Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRCCS /ID# 224071

Meldola 47014

0 studies enrolling now · 1 studies all time

What they study most

Myeloproliferative Neoplasm

Studies at this site

• A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm — Running, not enrolling